Webinar, page-46

Capital Raise you say? I don't see it:

• Profitable in burns business already - discussed by Dr Perry on recent Investor recording (on the website)
• Heaps of cash in the bank 105million US
• 2 studies (vitiligo and soft tissue) have completed enrolment
• Recently announced BARDA funding of soft tissue trial (details still to follow not released yet)
• Japan marketing is zero cost risk as COSMOTEC is funding and arranging all of that
• FDA approval and then start selling into 2 huge markets vitiligo and soft tissue next year

I don't see the capital raise you allude to?
I see no further capital raise at all.
I see the previous capital raises at much higher SP as simply a brilliant move by AVITA Medical it has reduced dilution and we now have a sizeable war chest to complete the main current pipeline objectives with selling into the large new markets of vitiligo and soft tissue reconstruction NEXT year.